Clinical Application of an Open-source Artificial Pancreas System in Adult Inpatients With Diabetes

Exclusion Criteria

• •1. Patients who are not suitable for insulin pump therapy;
• •2. Acute complications of diabetes, such as diabetic ketoacidosis, diabetic hyperosmolar non-ketotic coma;
• •3. Hyperglycemia with severe circulatory disorders and patients with shock;
• •4. Cardiac function grade III or above; ALT or AST exceeds the upper limit of normal value by more than 3 times; Serum creatinine more than 442μmol/L; Hemoglobin less than 90g/L; White blood cell count \< 4.0×109/L or platelet count \<90×109/L;
• •5. Those who are allergic to adhesive tape;
• •6. Patients with skin diseases such as rash and prurigo, or abnormal coagulation function;
• •7. Women who are pregnant or lactating, or those who have a family plan during clinical trials;
• •8. Those who suffer from mental illness, have no self-control, and cannot express themselves clearly;
• •9. Those who have participated in clinical studies of other drugs, biologics or medical devices before screening but have not reached the time limit of the primary research endpoint;
• •10. Other circumstances that participants deems inappropriate to participate in the clinical trial.